Electronic cigarettes have become increasingly popular during the past decade as a potentially safer alternative to smoking cigarettes or other tobacco products. But studies suggest that using e-cigarettes, or vaping, also carries health risks.

Personalized kidney screening for people with type 1 diabetes (T1D) may reduce costs and help detect chronic kidney disease (CKD) earlier, according to a new analysis performed by the Epidemiology of Diabetes Interventions and Complications study group, funded by NIDDK.

Adults with hypertension saw a small but consequential rise in their blood pressure levels during the first eight months of the Covid-19 pandemic, while the number of times they had their blood pressure measured dropped significantly.

A three-dose course of the hepatitis B vaccine HEPLISAV-B fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to study findings from an ongoing NIAID-sponsored phase-3 study.

A study of nearly 2,000 children found that those who reported playing video games for three hours per day or more performed better on cognitive skills tests involving impulse control and working memory compared to children who had never played video games.

Black adults treated at advanced heart failure centers received potentially life-changing therapies, such as transplants and heart pumps, about half as often as White adults, possibly due to racial bias. The finding comes from a small NIH-supported study.

NEI researchers mapped the organization of human retinal cell chromatin, the fibers that package 3 billion nucleotide-long DNA molecules into compact structures that fit into chromosomes within each cell’s nucleus.

An NIH study found an experimental approach added to allergy shots—a standard cat allergy treatment—made it more effective and faster acting, and the benefits persisted for a year after treatment ended.

A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose...

In a large, NIDDK-funded clinical trial comparing commonly used type 2 diabetes medications, researchers found that insulin glargine and liraglutide performed the best of four medications FDA-approved to maintain blood glucose levels in the recommended range.